Stock A099430 BIO PLUS CO., LTD
Add to a list
To use this feature you must be a member
Log inSign up

Company Bio Plus Co., Ltd

Equities

A099430

KR7099430001

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 23:00:00 23/05/2024 BST 		5-day change 1st Jan Change
4,830 KRW -1.33% Intraday chart for Bio Plus Co., Ltd -6.76% -29.69%
01-24 Elevance Health Offers Stronger-Than-Expected 2024 Earnings Outlook After Fourth-Quarter Beat MT
01-24 Elevance Health Issues Upbeat 2024 Adjusted. Earnings Outlook After 4Q Revenue Gains DJ

Business Summary

BioPlus Co Ltd is a Korea-based company principally engaged in the medical device business. The Company is engaged in the production and sale of biomaterials for tissue restoration used for temporary improvement of facial wrinkles, namely hyaluronic acid fillers. In addition, the Company is engaged in the production and sale of anti-adhesion agents that reduce the formation of adhesions in surgical areas, biomaterials for joint tissue repair, and other products.

Sales per Business

KRW in Million2022Weight2023Weight Delta
Medical Device Products
92.9 %
50,674 89.3 % 60,426 92.9 % +19.24%
Medical Device Merchandise
7.1 %
6,036 10.6 % 4,595 7.1 % -23.87%
Services
0.0 %
9 0.0 % 22 0.0 % +134.81%

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
100.0 %
56,719 100.0 % 65,043 100.0 % +14.68%

Managers

Managers TitleAgeSince
Hyun-Kyu Jung CEO
 Chief Executive Officer 67 28/02/13
Sung-Young Park CTO
 Chief Tech/Sci/R&D Officer 57 31/10/05
Min-Yup Lee BRD
 Director/Board Member 52 31/12/18
Se-Yoon Lee BRD
 Director/Board Member 65 31/10/18
Yong-Jun Jo PRN
 Corporate Officer/Principal 57 30/09/15

Members of the board

Members of the board TitleAgeSince
Hyun-Kyu Jung CEO
 Chief Executive Officer 67 28/02/13
Sung-Young Park CTO
 Chief Tech/Sci/R&D Officer 57 31/10/05
Se-Yoon Lee BRD
 Director/Board Member 65 31/10/18
Min-Yup Lee BRD
 Director/Board Member 52 31/12/18
Hyun-Duk Choi BRD
 Director/Board Member 58 28/02/21

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 57,930,864 39,399,671 ( 68.01 %) 743,436 ( 1.283 %) 68.01 %

Shareholders

NameEquities%Valuation
Hyun-Kyu Jung
23.14 %
13,405,352 23.14 % 62 M ₩
Lee Hae Young
3.673 %
2,128,000 3.673 % 10 M ₩
Jae-won Jung
3.001 %
1,738,457 3.001 % 8 M ₩
Bo-in Jung
2.798 %
1,621,056 2.798 % 8 M ₩
Sung-Young Park
2.610 %
1,512,000 2.610 % 7 M ₩
Min A Lee
1.768 %
1,024,000 1.768 % 5 M ₩
CUBE ENTERTAINMENT, INC.
1.466 %
848,989 1.466 % 4 M ₩
Sook-won Ok
1.118 %
647,672 1.118 % 3 M ₩
Jae-wook Sun
0.3663 %
212,188 0.3663 % 988 707 ₩
BioPlus Co., Ltd. ESOA
0.2900 %
168,000 0.2900 % 782 809 ₩

Company contact information

BioPlus Co., Ltd.

Seongnam Woolim Lions Valley 2cha 14 Sagimakgol-ro 45beon-gil

13209, Seongnam-si

+

http://www.ubioplus.com
address Bio Plus Co., Ltd(A099430)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Biopharmaceuticals

Sales per Business

Quarterly revenue - Rate of surprise

Company calendar

Sector Biopharmaceuticals

1st Jan change Capi.
BIO PLUS CO., LTD Stock Bio Plus Co., Ltd
-29.69% 202M
CSL LIMITED Stock CSL Limited
-2.10% 90.02B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
-1.18% 39.15B
BIOGEN INC. Stock Biogen Inc.
-15.83% 31.71B
UCB Stock UCB
+62.10% 26.47B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
-21.68% 14.34B
INCYTE CORPORATION Stock Incyte Corporation
-8.73% 12.89B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-15.05% 11.18B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-45.69% 10.97B
SWEDISH ORPHAN BIOVITRUM AB Stock Swedish Orphan Biovitrum AB
+3.97% 8.94B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. A099430 Stock
  4. Company Bio Plus Co., Ltd